This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of ofatumumab in reducing disease activity, pain, and improving function in people with RA.
CITATION STYLE
Anand, V., Garg, S. K., Lopez-Olivo, M. A., & Singh, J. A. (2013). Ofatumumab for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2013(11). https://doi.org/10.1002/14651858.CD010833
Mendeley helps you to discover research relevant for your work.